Form 990 for tax year 2023

Totals

Total revenue

$0

Total expenses

$126,327

Contributions and grants received

$0

Grants paid

$126,327

Program service revenue

$0

Investment income

$0

Other revenue

$0

Total assets, end of year

$0

Total liabilities, end of year

$0

Net assets or fund balances, end of year

$0

Program services expenses (Part IX)

$126,327

Management and general expenses

$0

Fundraising expenses

$0

Program service expenses (Part III)

$126,327

Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2023

• APPLIED MEDICAL RESEARCH INC. (AMR), CURRENTLY D/B/A DREYFUS HEALTH POLICY AND RESEARCH CENTER, AS A 501(C)3 ENTITY, HAS AS ITS ONLY PURPOSE, BENEFITING THE HEALTH AND WELL-BEING OF ALL PEOPLE IN THE UNITED STATES OF AMERICA. ITS EMPHASIS IS ON THE MAINTENANCE OF WELLNESS AND THE PREVENTION OF THOSE COMMON CHRONIC DISEASES INCLUDING, BUT NOT LIMITED TO, OBESITY, DIABETES, AND HYPERTENSION, THAT LEAD TO CHRONIC KIDNEY DISEASE (CKD) AND, ULTIMATELY, END-STAGE RENAL DISEASE (ESRD) OR KIDNEY FAILURE, REQUIRING TREATMENT WITH DIALYSIS AND/OR KIDNEY TRANSPLANTATION. KIDNEY DISEASE, AS CKD OR ESRD, CURRENTLY AFFECTS SOME 40,000,000 AMERICANS AND IS NOT ONLY VERY COSTLY IN STRICTLY ECONOMIC TERMS, BUT ALSO IN RELATION TO VARIOUS TYPES OF HUMAN (AND FAMILY) SUFFERING. APPLIED MEDICAL RESEARCH INC., AS NOTED ABOVE, IS COMMITTED TO MAXIMIZING WELLNESS AND PREVENTING THE MOST COMMON CHRONIC DISEASES THAT LEAD TO KIDNEY DISEASE AND THE ECONOMIC COST AND HUMAN SUFFERING ASSOCIATED WITH IT. TO ACHIEVE THAT END, AMR IS DEVELOPING AND TESTING (IN REAL-LIFE SITUATIONS) COMPREHENSIVE AND RIGOROUS COMMUNITY-LEVEL MODELS OF HEALTH OPTIMIZATION AND ARTIFICIAL-INTELLIGENCE-BASED RISK STRATIFICATION ALGORITHMS THAT CAN IDENTIFY THOSE INDIVIDUALS MOST AT RISK. THIS ENABLES REFERRAL FOR APPROPRIATE INTERVENTIONS TO TREAT THE UNDERLYING CONDITIONS AND THUS PREVENT KIDNEY DISEASE AND THE ENORMOUS ADVERSE MEDICAL AND HUMAN CONSEQUENCES ASSOCIATED WITH IT. A CENTRAL PRINCIPLE OF THIS EFFORT IS THE CONVICTION THAT TOTAL (TRUE) HEALTH IS A PRODUCT OF THE DEGREE OF FUNCTIONALITY OR DYSFUNCTIONALITY OF PARTICULAR COMMUNITIES, SO THAT TRULY EFFECTIVE EFFORTS MUST BE MULTI-FUNCTIONAL AND INVOLVE THE COMMUNITIES THEMSELVES AS THE DRIVERS AND LEADERS. AMR'S CURRENT EFFORT IS ONGOING IN EAST NEW YORK, BROOKLYN, AN UNDERSERVED COMMUNITY OF NEW YORK CITY. BASED ON THE SUCCESS ACHIEVED TO DATE, ACTIVE PLANNING TO EXTEND THE MODEL TO OTHER UNDERSERVED COMMUNITIES IN THE UNITED STATES IS BEING CARRIED, OUT IN PARTNERSHIP WITH AMR-AFFILIATE AND PARENT DIALYSIS CLINIC INC., WHICH HAS KIDNEY-DISEASE TREATMENT (DIALYSIS) FACILITIES IN TWENTY-EIGHT STATES AND THREE ORGAN PROCUREMENT ORGANIZATIONS (MIDDLE TENNESSEE, NEW MEXICO, AND NORTHERN CALIFORNIA.

  Expenses $126,327 · Grants $126,327

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• DREYFUS HEALTH POLICY & RESEARCH CENTER INC

  $126,327

  GENERAL SUPPORT

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

• DIALYSIS CLINIC INC

  501(C)(3) · KIDNEY DIALYSIS · TN

• DCI DONOR SERVICES INC

  501(C)(3) · ORGAN PROCUREMENT · TN · controlled entity

  Directly controlled by DIALYSIS CLINIC INC

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Assets distributed on this return

Schedule N, as filed: what the organization did with its assets when it liquidated or dissolved, or disposed of more than a quarter of them, and who received them. A recipient with an EIN is usually a successor organization; filers also list expenses such as legal fees here.

• DREYFUS HEALTH POLICY & RESEARCH

  $126,327

  Disposition · CASH · Feb 23, 2024 · 501(C)(3)

Provenance

Return type

form_990

Tax year

2023

Filed

14 August 2025

IRS schema version

2023v6.0

Source object

202542279349300244

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.